Startup · $2.1m raised

Respirion Pharmaceuticals Pty Ltd

Developing inhaled RSP-1502 to treat resistant infection and inflammation in cystic fibrosis

Investors

Every investor coverage indicates participated in a round Respirion Pharmaceuticals Pty Ltd raised.

Investor	Rounds	Invested
Brandon BioCatalyst	Accelerator · Grant	-
Innovation Seed Fund	Grant	-
WA Future Health Research and Innovation Fund	Grant	-

What Respirion Pharmaceuticals Pty Ltd bought

Companies Respirion Pharmaceuticals Pty Ltd acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Respirion Pharmaceuticals Pty Ltd is not recorded as having acquired anything.

Something wrong? Tell us

Respirion Pharmaceuticals Pty Ltd

Funding history

Investors

What Respirion Pharmaceuticals Pty Ltd bought

People

Coverage

Cheque-in: 17 ANZ startups – plus Brooki and The Memo – raised $59.61 million this week

Western Australia backs 12 medtech startup ideas with $5 million in Seed funding

Respirion offers hope for people living with cystic fibrosis

Respirion offers hope for people living with cystic fibrosis

Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential